First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon EGFR Mutations: The UNICORN Phase 2 Nonrandomized Clinical Trial.
| Autor: | Okuma, Yusuke, Kubota, Kaoru, Shimokawa, Mototsugu, Hashimoto, Kana, Kawashima, Yosuke, Sakamoto, Tomohiro, Wakui, Hiroshi, Murakami, Shuji, Okishio, Kyoichi, Hayashihara, Kenji, Ohe, Yuichiro |
|---|---|
| Zdroj: | JAMA Oncology; Jan2024, Vol. 10 Issue 1, p43-51, 9p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|